Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 9 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005681 | spliceosomal complex | 3 | 12 |
GO:0032991 | protein-containing complex | 1 | 12 |
GO:0140513 | nuclear protein-containing complex | 2 | 12 |
GO:1990904 | ribonucleoprotein complex | 2 | 12 |
Related structures:
AlphaFold database: E9AMI8
Term | Name | Level | Count |
---|---|---|---|
GO:0000375 | RNA splicing, via transesterification reactions | 8 | 12 |
GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 9 | 12 |
GO:0000398 | mRNA splicing, via spliceosome | 8 | 12 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 12 |
GO:0006396 | RNA processing | 6 | 12 |
GO:0006397 | mRNA processing | 7 | 12 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 12 |
GO:0006807 | nitrogen compound metabolic process | 2 | 12 |
GO:0008152 | metabolic process | 1 | 12 |
GO:0008380 | RNA splicing | 7 | 12 |
GO:0009987 | cellular process | 1 | 12 |
GO:0016070 | RNA metabolic process | 5 | 12 |
GO:0016071 | mRNA metabolic process | 6 | 12 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 12 |
GO:0043170 | macromolecule metabolic process | 3 | 12 |
GO:0044237 | cellular metabolic process | 2 | 12 |
GO:0044238 | primary metabolic process | 2 | 12 |
GO:0046483 | heterocycle metabolic process | 3 | 12 |
GO:0071704 | organic substance metabolic process | 2 | 12 |
GO:0090304 | nucleic acid metabolic process | 4 | 12 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 12 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000386 | second spliceosomal transesterification activity | 4 | 12 |
GO:0003676 | nucleic acid binding | 3 | 12 |
GO:0003723 | RNA binding | 4 | 12 |
GO:0003824 | catalytic activity | 1 | 12 |
GO:0005488 | binding | 1 | 12 |
GO:0030628 | pre-mRNA 3'-splice site binding | 6 | 12 |
GO:0036002 | pre-mRNA binding | 5 | 12 |
GO:0097159 | organic cyclic compound binding | 2 | 12 |
GO:0140098 | catalytic activity, acting on RNA | 3 | 12 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 12 |
GO:1901363 | heterocyclic compound binding | 2 | 12 |
GO:0008270 | zinc ion binding | 6 | 1 |
GO:0043167 | ion binding | 2 | 1 |
GO:0043169 | cation binding | 3 | 1 |
GO:0046872 | metal ion binding | 4 | 1 |
GO:0046914 | transition metal ion binding | 5 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 215 | 219 | PF00656 | 0.583 |
CLV_NRD_NRD_1 | 27 | 29 | PF00675 | 0.435 |
CLV_NRD_NRD_1 | 282 | 284 | PF00675 | 0.539 |
CLV_NRD_NRD_1 | 70 | 72 | PF00675 | 0.563 |
CLV_PCSK_KEX2_1 | 151 | 153 | PF00082 | 0.466 |
CLV_PCSK_KEX2_1 | 282 | 284 | PF00082 | 0.519 |
CLV_PCSK_KEX2_1 | 404 | 406 | PF00082 | 0.409 |
CLV_PCSK_PC1ET2_1 | 151 | 153 | PF00082 | 0.466 |
CLV_PCSK_PC1ET2_1 | 404 | 406 | PF00082 | 0.452 |
CLV_PCSK_SKI1_1 | 15 | 19 | PF00082 | 0.596 |
CLV_PCSK_SKI1_1 | 263 | 267 | PF00082 | 0.458 |
CLV_PCSK_SKI1_1 | 305 | 309 | PF00082 | 0.700 |
CLV_PCSK_SKI1_1 | 408 | 412 | PF00082 | 0.386 |
DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.757 |
DEG_SPOP_SBC_1 | 333 | 337 | PF00917 | 0.733 |
DEG_SPOP_SBC_1 | 343 | 347 | PF00917 | 0.726 |
DEG_SPOP_SBC_1 | 354 | 358 | PF00917 | 0.616 |
DOC_AGCK_PIF_2 | 272 | 277 | PF00069 | 0.564 |
DOC_CYCLIN_yClb3_PxF_3 | 47 | 55 | PF00134 | 0.553 |
DOC_MAPK_DCC_7 | 28 | 37 | PF00069 | 0.469 |
DOC_MAPK_gen_1 | 151 | 161 | PF00069 | 0.542 |
DOC_MAPK_MEF2A_6 | 154 | 163 | PF00069 | 0.579 |
DOC_PP4_FxxP_1 | 221 | 224 | PF00568 | 0.506 |
DOC_USP7_MATH_1 | 235 | 239 | PF00917 | 0.477 |
DOC_USP7_MATH_1 | 342 | 346 | PF00917 | 0.598 |
DOC_USP7_MATH_1 | 365 | 369 | PF00917 | 0.664 |
DOC_USP7_UBL2_3 | 205 | 209 | PF12436 | 0.492 |
DOC_USP7_UBL2_3 | 404 | 408 | PF12436 | 0.505 |
DOC_WW_Pin1_4 | 307 | 312 | PF00397 | 0.663 |
DOC_WW_Pin1_4 | 344 | 349 | PF00397 | 0.732 |
DOC_WW_Pin1_4 | 43 | 48 | PF00397 | 0.442 |
LIG_14-3-3_CanoR_1 | 112 | 120 | PF00244 | 0.488 |
LIG_APCC_ABBA_1 | 139 | 144 | PF00400 | 0.537 |
LIG_BRCT_BRCA1_1 | 116 | 120 | PF00533 | 0.570 |
LIG_BRCT_BRCA1_1 | 268 | 272 | PF00533 | 0.484 |
LIG_FHA_1 | 129 | 135 | PF00498 | 0.527 |
LIG_FHA_1 | 302 | 308 | PF00498 | 0.723 |
LIG_FHA_1 | 9 | 15 | PF00498 | 0.558 |
LIG_FHA_2 | 133 | 139 | PF00498 | 0.460 |
LIG_FHA_2 | 308 | 314 | PF00498 | 0.522 |
LIG_FHA_2 | 39 | 45 | PF00498 | 0.507 |
LIG_Integrin_RGD_1 | 243 | 245 | PF01839 | 0.484 |
LIG_LIR_Apic_2 | 218 | 224 | PF02991 | 0.549 |
LIG_LIR_Apic_2 | 389 | 393 | PF02991 | 0.510 |
LIG_LIR_Gen_1 | 253 | 262 | PF02991 | 0.441 |
LIG_LIR_Gen_1 | 269 | 280 | PF02991 | 0.456 |
LIG_LIR_Nem_3 | 251 | 257 | PF02991 | 0.457 |
LIG_LIR_Nem_3 | 259 | 265 | PF02991 | 0.428 |
LIG_LIR_Nem_3 | 269 | 275 | PF02991 | 0.448 |
LIG_LIR_Nem_3 | 389 | 394 | PF02991 | 0.478 |
LIG_PDZ_Class_1 | 413 | 418 | PF00595 | 0.678 |
LIG_SH2_CRK | 262 | 266 | PF00017 | 0.525 |
LIG_SH2_GRB2like | 130 | 133 | PF00017 | 0.579 |
LIG_SH2_GRB2like | 254 | 257 | PF00017 | 0.580 |
LIG_SH2_SRC | 257 | 260 | PF00017 | 0.539 |
LIG_SH2_STAP1 | 130 | 134 | PF00017 | 0.566 |
LIG_SH2_STAT5 | 130 | 133 | PF00017 | 0.579 |
LIG_SH2_STAT5 | 210 | 213 | PF00017 | 0.510 |
LIG_SH2_STAT5 | 257 | 260 | PF00017 | 0.437 |
LIG_SH2_STAT5 | 390 | 393 | PF00017 | 0.400 |
LIG_SH3_2 | 5 | 10 | PF14604 | 0.431 |
LIG_SH3_3 | 175 | 181 | PF00018 | 0.700 |
LIG_SH3_3 | 2 | 8 | PF00018 | 0.447 |
LIG_SH3_3 | 345 | 351 | PF00018 | 0.675 |
LIG_SH3_3 | 44 | 50 | PF00018 | 0.435 |
LIG_SUMO_SIM_anti_2 | 328 | 338 | PF11976 | 0.448 |
LIG_SUMO_SIM_par_1 | 33 | 41 | PF11976 | 0.448 |
LIG_TRAF2_1 | 41 | 44 | PF00917 | 0.495 |
LIG_TRFH_1 | 30 | 34 | PF08558 | 0.449 |
MOD_CK1_1 | 128 | 134 | PF00069 | 0.550 |
MOD_CK1_1 | 334 | 340 | PF00069 | 0.655 |
MOD_CK1_1 | 375 | 381 | PF00069 | 0.563 |
MOD_CK1_1 | 99 | 105 | PF00069 | 0.577 |
MOD_CK2_1 | 134 | 140 | PF00069 | 0.542 |
MOD_CK2_1 | 332 | 338 | PF00069 | 0.643 |
MOD_CK2_1 | 38 | 44 | PF00069 | 0.464 |
MOD_CK2_1 | 73 | 79 | PF00069 | 0.492 |
MOD_GlcNHglycan | 412 | 416 | PF01048 | 0.574 |
MOD_GlcNHglycan | 75 | 78 | PF01048 | 0.677 |
MOD_GSK3_1 | 110 | 117 | PF00069 | 0.486 |
MOD_GSK3_1 | 128 | 135 | PF00069 | 0.427 |
MOD_GSK3_1 | 301 | 308 | PF00069 | 0.661 |
MOD_GSK3_1 | 315 | 322 | PF00069 | 0.429 |
MOD_GSK3_1 | 332 | 339 | PF00069 | 0.576 |
MOD_GSK3_1 | 353 | 360 | PF00069 | 0.584 |
MOD_GSK3_1 | 361 | 368 | PF00069 | 0.538 |
MOD_GSK3_1 | 372 | 379 | PF00069 | 0.619 |
MOD_NEK2_1 | 315 | 320 | PF00069 | 0.489 |
MOD_NEK2_1 | 355 | 360 | PF00069 | 0.719 |
MOD_PIKK_1 | 146 | 152 | PF00454 | 0.603 |
MOD_PIKK_1 | 257 | 263 | PF00454 | 0.532 |
MOD_PIKK_1 | 320 | 326 | PF00454 | 0.663 |
MOD_PK_1 | 10 | 16 | PF00069 | 0.633 |
MOD_PK_1 | 125 | 131 | PF00069 | 0.495 |
MOD_PKA_1 | 9 | 15 | PF00069 | 0.689 |
MOD_PKA_2 | 132 | 138 | PF00069 | 0.559 |
MOD_PKA_2 | 99 | 105 | PF00069 | 0.542 |
MOD_Plk_1 | 172 | 178 | PF00069 | 0.504 |
MOD_Plk_2-3 | 172 | 178 | PF00069 | 0.504 |
MOD_Plk_4 | 125 | 131 | PF00069 | 0.529 |
MOD_Plk_4 | 372 | 378 | PF00069 | 0.647 |
MOD_Plk_4 | 386 | 392 | PF00069 | 0.323 |
MOD_Plk_4 | 63 | 69 | PF00069 | 0.579 |
MOD_ProDKin_1 | 307 | 313 | PF00069 | 0.658 |
MOD_ProDKin_1 | 344 | 350 | PF00069 | 0.728 |
MOD_ProDKin_1 | 43 | 49 | PF00069 | 0.438 |
MOD_SUMO_rev_2 | 138 | 147 | PF00179 | 0.577 |
MOD_SUMO_rev_2 | 2 | 11 | PF00179 | 0.655 |
MOD_SUMO_rev_2 | 218 | 226 | PF00179 | 0.522 |
MOD_SUMO_rev_2 | 334 | 342 | PF00179 | 0.755 |
MOD_SUMO_rev_2 | 81 | 89 | PF00179 | 0.629 |
TRG_ENDOCYTIC_2 | 255 | 258 | PF00928 | 0.447 |
TRG_ENDOCYTIC_2 | 262 | 265 | PF00928 | 0.434 |
TRG_ER_diArg_1 | 185 | 188 | PF00400 | 0.623 |
TRG_ER_diArg_1 | 281 | 283 | PF00400 | 0.594 |
TRG_Pf-PMV_PEXEL_1 | 15 | 20 | PF00026 | 0.499 |
TRG_Pf-PMV_PEXEL_1 | 22 | 26 | PF00026 | 0.399 |
TRG_Pf-PMV_PEXEL_1 | 263 | 268 | PF00026 | 0.419 |
TRG_Pf-PMV_PEXEL_1 | 305 | 309 | PF00026 | 0.642 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PD09 | Leptomonas seymouri | 68% | 98% |
A0A0S4IP46 | Bodo saltans | 37% | 97% |
A0A1X0NEY6 | Trypanosomatidae | 48% | 92% |
A0A3R7NLB9 | Trypanosoma rangeli | 46% | 99% |
A0A3S5H692 | Leishmania donovani | 96% | 100% |
A4H5F6 | Leishmania braziliensis | 84% | 100% |
A4HTQ1 | Leishmania infantum | 95% | 100% |
C9ZPF5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 48% | 87% |
O23174 | Arabidopsis thaliana | 26% | 78% |
P0CR52 | Cryptococcus neoformans var. neoformans serotype D (strain JEC21 / ATCC MYA-565) | 27% | 73% |
P0CR53 | Cryptococcus neoformans var. neoformans serotype D (strain B-3501A) | 27% | 73% |
Q3KQD1 | Xenopus laevis | 27% | 72% |
Q3ZBE5 | Bos taurus | 25% | 71% |
Q4QI51 | Leishmania major | 96% | 100% |
Q4R4P2 | Macaca fascicularis | 25% | 71% |
Q4WWR2 | Neosartorya fumigata (strain ATCC MYA-4609 / Af293 / CBS 101355 / FGSC A1100) | 26% | 88% |
Q51LA6 | Magnaporthe oryzae (strain 70-15 / ATCC MYA-4617 / FGSC 8958) | 24% | 88% |
Q54TA0 | Dictyostelium discoideum | 27% | 75% |
Q5B3U2 | Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) | 25% | 90% |
Q5U3F2 | Danio rerio | 27% | 73% |
Q5ZIG2 | Gallus gallus | 31% | 74% |
Q7SDY6 | Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) | 24% | 100% |
Q9SHY8 | Arabidopsis thaliana | 26% | 78% |
V5DAD7 | Trypanosoma cruzi | 46% | 90% |